The Medicines Company's Publishes Phase III Data from Trials of IV Cangrelor

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

TheMedicines Company (NASDAQ: MDCO) today reported presentation andpublication of a pooled analysis of three Phase III clinical trialsof an investigational intravenous (IV) antiplatelet, cangrelor. Thetrials compared IV cangrelor to either oral clopidogrel or placebofor prevention of thrombotic (clotting) complications during andafter percutaneous coronary intervention (PCI). The findings of thepooled CHAMPION program confirm the results of the CHAMPION PHOENIXtrial presented and published in April 2013.This pre-specified, pooled analysis of patient-level data fromCHAMPION-PCI, CHAMPION-PLATFORM, and CHAMPION-PHOENIX was presentedat the European Society of Cardiology today and concurrentlypublished in The Lancet.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!